A detailed history of Trustees Of Columbia University In The City Of New York transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Trustees Of Columbia University In The City Of New York holds 192,973 shares of VIGL stock, worth $314,545. This represents 1.39% of its overall portfolio holdings.

Number of Shares
192,973
Previous 192,973 -0.0%
Holding current value
$314,545
Previous $1.04 Million 37.31%
% of portfolio
1.39%
Previous 2.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$8.74 - $15.99 $1.69 Million - $3.09 Million
192,973 New
192,973 $2.41 Million

Others Institutions Holding VIGL

About Vigil Neuroscience, Inc.


  • Ticker VIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,268,600
  • Market Cap $46.1M
  • Description
  • Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...
More about VIGL
Track This Portfolio

Track Trustees Of Columbia University In The City Of New York Portfolio

Follow Trustees Of Columbia University In The City Of New York and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustees Of Columbia University In The City Of New York, based on Form 13F filings with the SEC.

News

Stay updated on Trustees Of Columbia University In The City Of New York with notifications on news.